Literature DB >> 24821729

Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis.

Philip M Hansbro1, Matthew J Hamilton2, Michael Fricker1, Shaan L Gellatly1, Andrew G Jarnicki1, Dominick Zheng2, Sandra M Frei2, G William Wong3, Sahar Hamadi2, Saijun Zhou4, Paul S Foster1, Steven A Krilis4, Richard L Stevens5.   

Abstract

Protease serine member S31 (Prss31)/transmembrane tryptase/tryptase-γ is a mast cell (MC)-restricted protease of unknown function that is retained on the outer leaflet of the plasma membrane when MCs are activated. We determined the nucleotide sequences of the Prss31 gene in different mouse strains and then used a Cre/loxP homologous recombination approach to create a novel Prss31(-/-) C57BL/6 mouse line. The resulting animals exhibited no obvious developmental abnormality, contained normal numbers of granulated MCs in their tissues, and did not compensate for their loss of the membrane tryptase by increasing their expression of other granule proteases. When Prss31-null MCs were activated with a calcium ionophore or by their high affinity IgE receptors, they degranulated in a pattern similar to that of WT MCs. Prss31-null mice had increased baseline airway reactivity to methacholine but markedly reduced experimental chronic obstructive pulmonary disease and colitis, thereby indicating both beneficial and adverse functional roles for the tryptase. In a cigarette smoke-induced model of chronic obstructive pulmonary disease, WT mice had more pulmonary macrophages, higher histopathology scores, and more fibrosis in their small airways than similarly treated Prss31-null mice. In a dextran sodium sulfate-induced acute colitis model, WT mice lost more weight, had higher histopathology scores, and contained more Cxcl-2 and IL-6 mRNA in their colons than similarly treated Prss31-null mice. The accumulated data raise the possibility that inhibitors of this membrane tryptase may provide additional therapeutic benefit in the treatment of humans with these MC-dependent inflammatory diseases.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Chronic Obstructive Pulmonary Disease (COPD); Inflammation; Inflammatory Bowel Disease (IBD); Mast Cell; Protease

Mesh:

Substances:

Year:  2014        PMID: 24821729      PMCID: PMC4140286          DOI: 10.1074/jbc.M114.548594

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties.

Authors:  L Enerbäck
Journal:  Acta Pathol Microbiol Scand       Date:  1966

2.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

3.  Detection of an alteration of the alpha 2-macroglobulin gene in a patient with chronic lung disease and serum alpha 2-macroglobulin deficiency.

Authors:  W Poller; J Barth; B Voss
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

4.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

Authors:  B L Gruber; M J Marchese; K Suzuki; L B Schwartz; Y Okada; H Nagase; N S Ramamurthy
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

5.  Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow.

Authors:  E Razin; J M Mencia-Huerta; R A Lewis; E J Corey; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation.

Authors:  Y Kitamura; S Go; K Hatanaka
Journal:  Blood       Date:  1978-08       Impact factor: 22.113

7.  N-Acetyl-beta-glucosaminidases in human spleen.

Authors:  D Robinson; J L Stirling
Journal:  Biochem J       Date:  1968-04       Impact factor: 3.857

8.  Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.

Authors:  E Razin; J N Ihle; D Seldin; J M Mencia-Huerta; H R Katz; P A LeBlanc; A Hein; J P Caulfield; K F Austen; R L Stevens
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

9.  Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases.

Authors:  D S Reynolds; R L Stevens; W S Lane; M H Carr; K F Austen; W E Serafin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Activation of latent rheumatoid synovial collagenase by human mast cell tryptase.

Authors:  B L Gruber; L B Schwartz; N S Ramamurthy; A M Irani; M J Marchese
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

View more
  30 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Alan C-Y Hsu; Prema M Nair; Tatt Jhong Haw; Michael Fricker; Shaan L Gellatly; Richard Y Kim; Mark D Inman; Gavin Tjin; Peter A B Wark; Marjorie M Walker; Jay C Horvat; Brian G Oliver; W Scott Argraves; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2016-06-16

Review 3.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

4.  MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

Authors:  Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark
Journal:  JCI Insight       Date:  2017-04-06

Review 5.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

6.  The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.

Authors:  A G Jarnicki; H Schilter; G Liu; K Wheeldon; A-T Essilfie; J S Foot; T T Yow; W Jarolimek; P M Hansbro
Journal:  Br J Pharmacol       Date:  2016-10-12       Impact factor: 8.739

Review 7.  The multifaceted mast cell in inflammatory bowel disease.

Authors:  Matthew J Hamilton; Sandra M Frei; Richard L Stevens
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

8.  IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis.

Authors:  Malcolm R Starkey; Maximilian W Plank; Paolo Casolari; Alberto Papi; Stelios Pavlidis; Yike Guo; Guy J M Cameron; Tatt Jhong Haw; Anthony Tam; Ma'en Obiedat; Chantal Donovan; Nicole G Hansbro; Duc H Nguyen; Prema Mono Nair; Richard Y Kim; Jay C Horvat; Gerard E Kaiko; Scott K Durum; Peter A Wark; Don D Sin; Gaetano Caramori; Ian M Adcock; Paul S Foster; Philip M Hansbro
Journal:  Eur Respir J       Date:  2019-07-18       Impact factor: 16.671

9.  Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Theo Borghuis; Prema M Nair; Gavin Tjin; Alan C Hsu; Tatt Jhong Haw; Michael Fricker; Celeste L Harrison; Bernadette Jones; Nicole G Hansbro; Peter A Wark; Jay C Horvat; W Scott Argraves; Brian G Oliver; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2019-07-25

10.  Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction.

Authors:  Michael Fricker; Bridie J Goggins; Sean Mateer; Bernadette Jones; Richard Y Kim; Shaan L Gellatly; Andrew G Jarnicki; Nicholas Powell; Brian G Oliver; Graham Radford-Smith; Nicholas J Talley; Marjorie M Walker; Simon Keely; Philip M Hansbro
Journal:  JCI Insight       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.